Prosight Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Sell |
472,687
-137,313
| -23% | -$5.93M | 4.98% | 5 |
|
|
2025
Q1 | $21.1M | Sell |
610,000
-385,000
| -39% | -$13.3M | 6.93% | 3 |
|
|
2024
Q4 | $27.3M | Sell |
995,000
-91,810
| -8% | -$2.52M | 7.55% | 3 |
|
|
2024
Q3 | $27.7M | Buy |
1,086,810
+286,810
| +36% | +$7.3M | 6.81% | 3 |
|
|
2024
Q2 | $20.3M | Buy |
800,000
+210,470
| +36% | +$5.33M | 6.06% | 4 |
|
|
2024
Q1 | $18.2M | Buy |
+589,530
| New | +$18.2M | 5.07% | 7 |
|
|
2023
Q2 | – | Sell |
-13,000
| Closed | -$216K | – | 37 |
|
|
2023
Q1 | $216K | Sell |
13,000
-76,027
| -85% | -$1.26M | 0.1% | 36 |
|
|
2022
Q4 | $678K | Buy |
+89,027
| New | +$678K | 0.37% | 31 |
|